Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#578 most reported symptom for this vaccine
Cardiac monitoring has been reported 45 times in association with Zoster Live (Zostavax) vaccination in VAERS. This represents 0.0% of all 140,312 reports for this vaccine.
Among these reports, 1 mentioned death (2.22%) and 18 involved hospitalization (40.0%).
Cardiac monitoring is the #578 most frequently reported symptom for Zoster Live (Zostavax) out of 2827 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 45 reports of Cardiac monitoring after Zoster Live (Zostavax) vaccination may seem alarming, but context is critical. With 140,312 total reports for this vaccine (representing many millions of doses), Cardiac monitoring appears in only 0.0% of reports.
The mortality rate of 2.22% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.